Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Caris Life Sciences Sues Foundation Medicine, Alleging Patent Infringement

Caris Life Sciences Sues Foundation Medicine, Alleging Patent Infringement

Nov 08, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Caris Life Sciences filed a patent infringement lawsuit against Foundation Medicine yesterday in the US District Court for the District of Massachusetts Boston Division.

The Irving, Texas-based company claims that three of Foundation Medicine's cancer genomic profiling tests — FoundationOne for solid tumors, FoundationOne Heme for hematological tumors and sarcomas, and the liquid biopsy test FoundationAct — infringe five of its US patents.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Preprints During Lockdown

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

ApoE and COVID-19

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Search for Genetic Clues to COVID-19 Severity

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

PNAS Papers on Retinal Development, Adoptive T Cell Transfer, Blood Cell Differentiation

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

What's Popular?

In Molecular Diagnostics

  1. NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test

  2. Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

    Premium

  3. AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

  4. With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

    Premium

  5. Exact Sciences, Express Gene, Avera Institute Get FDA EUAs for Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.